Form 4 Tracker
Immunovant, Inc.
IMVT

31 insider filings · Latest: Jun 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Apr 23, 2026Apr 24 8:05 PMJay S StoutChief Technology Officer
Sale
2,754$29.62$81.6K251,685(D)

View →

Apr 8, 2026Apr 10 8:05 PMTuyl Christopher VanChief Legal Officer
Sale
5,165$24.83$128.2K183,231(D)

View →

Apr 8, 2026Apr 10 8:03 PMMelanie GloriaChief Operating Officer
Sale
8,722$24.83$216.6K245,222(D)

View →

Apr 8, 2026Apr 10 8:02 PMJay S StoutChief Technology Officer
Sale
10,132$24.83$251.6K254,439(D)

View →

Apr 2, 2026Apr 3 8:33 PMEric VenkerDirector, Chief Executive Officer
Sale
14,229$24.10$342.9K19,561(D)

View →

Mar 18, 2026Mar 20 8:11 PMTuyl Christopher VanChief Legal Officer
Sale
2,877$24.97$71.8K147,053(D)

View →

Feb 25, 2026Feb 27 9:07 PMMelanie GloriaChief Operating Officer
Sale
3,238$27.85$90.2K170,273(D)

View →

Feb 10, 2026Feb 10 10:16 PMMICHAEL GEFFNER
Proposed Sale
5,800$26.77$155.2K

View →

Jan 21, 2026Jan 23 9:21 PMJay S StoutChief Technology Officer
Sale
1,977$26.03$51.5K197,634(D)

View →

Dec 1, 2025Dec 1 9:35 PMANDREW J FROMKIN
Proposed Sale
22,249$24.15$537.3K

View →

Dec 1, 2025Dec 1 9:34 PMDOUGLAS HUGHES
Proposed Sale
15,000$24.15$362.3K

View →

Nov 26, 2025Nov 26 10:07 PMMICHAEL GEFFNER
Proposed Sale
50,000$23.70$1.2M

View →

Nov 25, 2025Nov 26 12:16 AMMICHAEL GEFFNER
Proposed Sale
103,897$23.38$2.4M

View →

Jun 25, 2025Jun 25 8:02 PMWILLIAM MACIAS
Proposed Sale
30,000$15.83$474.9K

View →

Jun 13, 2025Jun 13 9:34 PMWILLIAM MACIAS
Proposed Sale
50,000$15.57$778.5K

View →

Jun 3, 2025Jun 3 9:42 PMWILLIAM MACIAS
Proposed Sale
80,000$15.61$1.2M

View →

May 21, 2025May 21 8:24 PMGEORGE V MIGAUSKY
Proposed Sale
21,812$14.58$318.0K

View →

May 19, 2025May 19 8:40 PMGEORGE V MIGAUSKY
Proposed Sale
28,188$14.58$410.9K

View →

Mar 7, 2025Mar 7 9:17 PMANDREW J FROMKIN
Proposed Sale
8,000$19.52$156.2K

View →

Feb 14, 2025Feb 14 9:11 PMMARK S LEVINE
Proposed Sale
69,763$20.16$1.4M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 26, 2026Jun 26 11:45 PMTuyl Christopher VanChief Legal Officer
Option Exercise
17,824$15.2053,707(D)

View →

Jun 26, 2026Jun 26 11:44 PMTiago GiraoChief Financial Officer
Option Exercise
10,000$15.90283,505(D)

View →

Jun 26, 2026Jun 26 11:43 PMAtul PandeDirector
Option Exercise
1,500$8.4368,181(D)

View →

Jun 15, 2026Jun 16 8:03 PMAtul PandeDirector
Option Exercise
1,500$8.4369,681(D)

View →

May 28, 2026May 29 8:04 PMAndrew J. FromkinDirector
Option Exercise
196,601$14.700(D)

View →

May 20, 2026May 21 1:22 AMAtul PandeDirector
Option Exercise
6,000$8.43270,252(D)

View →

Apr 7, 2026Apr 9 8:31 PMFrank TortiDirector
Grant/Award
88,325$24.6188,325(D)

View →

Apr 7, 2026Apr 9 8:28 PMAndrew J. FromkinDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:26 PMDouglas J. HughesDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:25 PMAtul PandeDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:23 PMJake BauerDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:22 PMRobert Graham SusmanDirector
Grant/Award
7,061$24.617,061(D)

View →

Apr 7, 2026Apr 9 8:20 PMMelanie GloriaChief Operating Officer
Grant/Award
121,063$24.61121,063(D)

View →

Apr 7, 2026Apr 9 8:19 PMJay S StoutChief Technology Officer
Grant/Award
96,851$24.6196,851(D)

View →

Apr 7, 2026Apr 9 8:17 PMTuyl Christopher VanChief Legal Officer
Grant/Award
59,820$24.6159,820(D)

View →

Apr 7, 2026Apr 9 8:13 PMEric VenkerDirector, Chief Executive Officer
Grant/Award
336,043$24.61336,043(D)

View →

Apr 7, 2026Apr 9 8:10 PMTiago GiraoChief Financial Officer
Grant/Award
94,002$24.6194,002(D)

View →

Apr 1, 2026Apr 3 8:33 PMEric VenkerDirector, Chief Executive Officer
Option Exercise
368,7501,106,250(D)

View →